• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
Expert Discusses Key Developments in Breath Biopsy

Expert Discusses Key Developments in Breath Biopsy

by Rachel Muenz | Aug 24, 2023 | News, Open Content

Owlstone Medical CEO discusses recent trends, the advantages of breath testing, and the challenges that must be met for wider clinical use.

Expert Q&A: The Latest in Breath Biopsy

Expert Q&A: The Latest in Breath Biopsy

by Rachel Muenz | Aug 23, 2023 | Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Special Focus-dtet

Owlstone Medical CEO Billy Boyle discusses the latest developments in breath biopsy and issues related to its wider clinical adoption.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
FDA Issues First Approval for SARS-CoV-2 Breathalyzer Test

FDA Issues First Approval for SARS-CoV-2 Breathalyzer Test

by Glenn S. Demby | May 2, 2022 | Articles, Essential, FDA-lir, Laboratory Industry Report

InspectIR COVID-19 device detects the virus from breath samples in less than three minutes, offering a new screening option.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
InspectIR Nabs First FDA Approval for a SARS-CoV-2 Breathalyzer

InspectIR Nabs First FDA Approval for a SARS-CoV-2 Breathalyzer

by Glenn S. Demby | Apr 25, 2022 | Articles, Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, FDA-dtet, Featured

On April 14, the FDA announced that, for the first time, it has granted Emergency Use Authorization for a COVID-19 breathalyzer test.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Quick COVID Breathalyzer Could Allow Mass Screening

Quick COVID Breathalyzer Could Allow Mass Screening

by American Chemical Society | Feb 11, 2022 | Articles, News, Open Content

According to experts, bringing an end to the pandemic will require rapid screening of people attending large gatherings, such as conferences and weddings. Even those who are asymptomatic can still transmit COVID-19 to others, making it important to identify and...
« Older Entries

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2025 G2Intelligence.com